Triculamin, Alboverticillin

General Information


DRACP ID  DRACP04460

Peptide Name   Triculamin, Alboverticillin

Sequence  SKKSKPGDGIRGKGVRG

Sequence Length  17

UniProt ID  Not available

PubChem CID  Not available

Origin  Bacteria

Type  Native peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  7ZWJ 

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C72H131N27O22

Absent amino acids  ACEFHLMNQTWY

Common amino acids  G

Mass  201256

Pl  11.82

Basic residues  6

Acidic residues  1

Hydrophobic residues  2

Net charge  5

Boman Index  -5390

Hydrophobicity  -144.71

Aliphatic Index  40

Half Life 
  Mammalian: 1.3 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  7

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 35748039

Title  Triculamin: An Unusual Lasso Peptide with Potent Antimycobacterial Activity

Doi Not available

Year  2022

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  19989

DRACP is developed by Dr.Zheng's team.